In the central nervous system, semaglutide acts on GLP-1 receptors in areas of the brain that regulate appetite and food intake, particularly the hypothalamus
Part of the issue is that the approved form of semaglutide can be acquired only from Novo Nordisk, the patent holder for Ozempic and Wegovy, and the company doesn't share drug ingredients with compounding pharmacists, Susan McCoy , executive director of the Mississippi Board of Pharmacy, told NBC News
However, the regulatory landscape is shifting, and patients should stay informed about FDA guidance changes that could affect availability
The doctor may increase your dose to 1.5 mg once a week and, in some cases, up to 3 mg or 4.5 mg depending on your tolerance and medical needs
Quick Picks by Your Need Heres the single best provider for each common need